Dynamics of Hepatitis B Virus Resistance to Lamivudine

Lamivudine was the first approved inhibitor of hepatitis B virus (HBV) reverse transcriptase (RT). Lamivudine resistance develops in 53% to 76% of patients after 3 years of treatment. We extensively characterized the dynamics of HBV quasispecies variant populations in four HBV-infected patients who...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pallier, Coralie, Castéra, Laurent, Soulier, Alexandre, Hézode, Christophe, Nordmann, Patrice, Dhumeaux, Daniel, Pawlotsky, Jean-Michel
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2006
Fag:
Vaccines and Antiviral Agents
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1346832/
https://ncbi.nlm.nih.gov/pubmed/16378967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.80.2.643-653.2006
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker